Antagonistic anti-LILRB1 monoclonal antibody regulates antitumor functions of natural killer cells
Chen H. et al. 2020. Journal for ImmunoTherapy of Cancer. 8(2):e000515.
Previous
Previous
Antagonist antibodies targeting LAIR1 promote inflammatory phenotype in myeloid cells and activate lymphocytes
Next
Next